Abel Gonzalez-Perez
Abel Gonzalez-Perez
Institut de Recerca Biomedica Barcelona
Verified email at - Homepage
Cited by
Cited by
The Cancer Genome Atlas Pan-Cancer analysis project
JMS The Cancer Genome Atlas Research Network, John N
Nature Genetics 45 (10), 1113–1120, 2013
Comprehensive characterization of cancer driver genes and mutations
MH Bailey, C Tokheim, E Porta-Pardo, S Sengupta, D Bertrand, ...
Cell 173 (2), 371-385. e18, 2018
Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin
KA Hoadley, C Yau, DM Wolf, AD Cherniack, D Tamborero, S Ng, ...
Cell 158 (4), 929-944, 2014
Pan-cancer analysis of whole genomes
Nature 578 (7793), 82-93, 2020
Improving the assessment of the outcome of nonsynonymous SNVs with a consensus deleteriousness score, Condel
A González-Pérez, N López-Bigas
The American Journal of Human Genetics 88 (4), 440-449, 2011
Pan-cancer network analysis identifies combinations of rare somatic mutations across pathways and protein complexes
MDM Leiserson, F Vandin, HT Wu, JR Dobson, JV Eldridge, JL Thomas, ...
Nature genetics 47 (2), 106-114, 2015
IntOGen-mutations identifies cancer drivers across tumor types
A Gonzalez-Perez, C Perez-Llamas, J Deu-Pons, D Tamborero, ...
Nature Methods, 2013
Comprehensive identification of mutational cancer driver genes across 12 tumor types
LBN Tamborero D*, Gonzalez-Perez A*, Perez-Llamas C
Scientific Reports 3, 2650, 2013
OncodriveCLUST: exploiting the positional clustering of somatic mutations to identify cancer genes
D Tamborero, A Gonzalez-Perez, N Lopez-Bigas
Bioinformatics 29 (18), 2238-2244, 2013
Analyses of non-coding somatic drivers in 2,658 cancer whole genomes
E Rheinbay, MM Nielsen, F Abascal, JA Wala, O Shapira, G Tiao, ...
Nature 578 (7793), 102-111, 2020
Functional impact bias reveals cancer drivers
A Gonzalez-Perez, N Lopez-Bigas
Nucleic Acids Research 40 (21), e169, 2012
Cancer Genome Interpreter annotates the biological and clinical relevance of tumor alterations
D Tamborero, C Rubio-Perez, J Deu-Pons, MP Schroeder, A Vivancos, ...
Genome medicine 10 (1), 1-8, 2018
A compendium of mutational cancer driver genes
F Martínez-Jiménez, F Muiños, I Sentís, J Deu-Pons, I Reyes-Salazar, ...
Nature Reviews Cancer 20 (10), 555-572, 2020
Pathway and network analysis of cancer genomes
P Creixell, J Reimand, S Haider, G Wu, T Shibata, M Vazquez, ...
Nature methods 12 (7), 615, 2015
In silico prescription of anticancer drugs to cohorts of 28 tumor types reveals targeting opportunities
C Rubio-Perez, D Tamborero, MP Schroeder, AA Antolín, J Deu-Pons, ...
Cancer cell 27 (3), 382-396, 2015
A framework to rank genomic alterations as targets for cancer precision medicine: the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT)
J Mateo, D Chakravarty, R Dienstmann, S Jezdic, A Gonzalez-Perez, ...
Annals of Oncology 29 (9), 1895-1902, 2018
Nucleotide excision repair is impaired by binding of transcription factors to DNA
S Radhakrishnan, L Mularoni, J Deu-Pons, A Gonzalez-Perez, ...
Nature, 264–267, 2016
Transcriptome characterization by RNA sequencing identifies a major molecular and clinical subdivision in chronic lymphocytic leukemia
PG Ferreira, P Jares, D Rico, G Gómez-López, A Martínez-Trillos, ...
Genome research 24 (2), 212-226, 2014
OncodriveFML: a general framework to identify coding and non-coding regions with cancer driver mutations
L Mularoni, R Sabarinathan, J Deu-Pons, A Gonzalez-Perez, ...
Genome biology 17 (1), 1-13, 2016
A Pan-cancer Landscape of Interactions between Solid Tumors and Infiltrating Immune Cell PopulationsTumor Features Associated to Immunophenotypes
D Tamborero, C Rubio-Perez, F Muiños, R Sabarinathan, JM Piulats, ...
Clinical Cancer Research 24 (15), 3717-3728, 2018
The system can't perform the operation now. Try again later.
Articles 1–20